164 related articles for article (PubMed ID: 11509332)
1. Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Schermuly RT; Weissmann N; Enke B; Ghofrani HA; Forssmann WG; Grimminger F; Seeger W; Walmrath D
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):219-25. PubMed ID: 11509332
[TBL] [Abstract][Full Text] [Related]
2. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Ghofrani HA; Enke B; Weissmann N; Grimminger F; Seeger W; Schudt C; Walmrath D
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112
[TBL] [Abstract][Full Text] [Related]
3. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
[TBL] [Abstract][Full Text] [Related]
4. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
Foubert L; De Wolf D; Mareels K; Van Belleghem Y; Reyntjens K; Mortier E; Van Nooten G
Pediatr Res; 2002 Nov; 52(5):730-6. PubMed ID: 12409521
[TBL] [Abstract][Full Text] [Related]
5. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
[TBL] [Abstract][Full Text] [Related]
6. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
[TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
[TBL] [Abstract][Full Text] [Related]
11. Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension.
Hori Y; Kondo C; Matsui M; Yamagishi M; Okano S; Chikazawa S; Kanai K; Hoshi F; Itoh N
Vet J; 2014 Nov; 202(2):334-9. PubMed ID: 25178687
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
13. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
14. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Leuchte H; Grimminger F; Seeger W; Walmrath D
Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1361-8. PubMed ID: 11704531
[TBL] [Abstract][Full Text] [Related]
15. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs.
Weissmann N; Voswinckel R; Tadic A; Hardebusch T; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):222-7. PubMed ID: 10919989
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
Dukarm RC; Morin FC; Russell JA; Steinhorn RH
Pediatr Res; 1998 Dec; 44(6):831-7. PubMed ID: 9853914
[TBL] [Abstract][Full Text] [Related]
18. Preserved pulmonary vasodilative properties of aerosolized brain natriuretic peptide.
Leuchte HH; Michalek J; Soenmez O; Meis T; Haziraj S; Cavalli V; Bevec D; Behr J
Pulm Pharmacol Ther; 2009 Dec; 22(6):548-53. PubMed ID: 19646544
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
20. Intermittent nitric oxide combined with intravenous dipyridamole in a piglet model of acute pulmonary hypertension.
Foubert L; De Wolf D; Reyntjens K; Van Belleghem Y; De Somer F; Van Nooten G; Mortier E
Anesth Analg; 2003 Nov; 97(5):1497-1500. PubMed ID: 14570673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]